YUSIMRY
NDC 71288-816, adalimumab-aqvh, injection, solution, from Meitheal Pharmaceuticals Inc..
- Product NDC
- 71288-816
- Status
- Listed
- Labeler
- Meitheal Pharmaceuticals Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761216
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71288-816 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADALIMUMAB40 mg/.8mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71288-816-81 | 71288081681 | 2 SYRINGE, GLASS in 1 CARTON (71288-816-81) / .8 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4cab600d-6950-409f-a6d8-d447da22cd95
Use it
Look up 71288-816 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71288-816 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71288-816. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.